0 avis
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles
Archive ouverte
Edité par CCSD ; Cell Press -
International audience. Highlights d Implementation hurdles restrict adoption of HRD testing, a PARPi response biomarker d GIInger leverages HRD-induced genome scarring from lowcoverage sequencing data d GIInger accurately stratifies ovarian cancer patients for PARPi treatment d GIInger is cost effective and seamlessly integrates into BRCA status workflows Authors